XML 168 R153.htm IDEA: XBRL DOCUMENT v3.21.4
Stock-based Compensation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Stock-Based Compensation    
Schedule of stock option activity

A summary of stock option awards outstanding as of September 30, 2021 and changes during the nine months then ended is as follows:

Weighted Average 

    

Number of Units

    

Exercise Price

Outstanding at January 1, 2021

7,478,736

$

0.68

Granted

 

3,720,500

 

8.18

Exercised

 

(1,830,071)

 

0.67

Forfeited

 

(472,211)

 

1.19

Outstanding at September 30, 2021

 

8,896,954

$

3.79

    

    

Weighted

    

Average

Weighted

Remaining

Aggregate

    

Number of

Average

Contractual

Intrinsic

    

Units

    

Exercise Price

    

Term (Years)

    

Value

Outstanding as of January 1, 2019

 

4,823,893

$

1.20

 

8.71

 

  

Granted

 

1,654,000

 

0.82

 

 

  

Exercised

 

(122,560)

 

0.33

 

 

  

Forfeited

 

(1,207,259)

 

1.33

 

 

  

Outstanding as of January 1, 2020

 

5,148,074

$

1.10

 

8.22

 

  

Granted

 

4,704,932

 

0.52

 

 

  

Exercised

 

(164,886)

 

(0.80)

 

 

  

Forfeited

 

(2,209,384)

 

(1.26)

 

 

  

Outstanding at December 31, 2020

 

7,478,736

$

0.68

 

8.35

$

6,058,137

Exercisable at December 31, 2020

 

3,142,881

$

0.81

 

7.30

$

2,173,188

Schedule of stock based compensation expense

Total stock-based compensation expense was classified in the statements of operations for the three and nine months ended September 30, 2021 and 2020 as follows:

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2021

    

2020

    

2021

    

2020

Cost of revenues

 

129,464

 

4,381

 

346,516

 

(70,058)

Selling, general and administrative

 

868,515

 

100,960

 

1,566,580

 

71,847

Total stock-based compensation expense

 

997,979

 

105,341

 

1,913,096

 

1,789

   

2020

   

2019

Cost of revenues

$

(64,919)

$

65,096

Selling, general and administrative

 

186,950

 

327,470

Total stock-based compensation expense

$

122,032

$

392,566

Schedule of stock options vested  

   

2020

   

2019

Total grant date fair value of stock options vested

$

533,089

$

643,425

Schedule of assumptions of valuing the stock options  

   

2020

   

2019

Expected term

6.25 years

2.25 years – 6.25 years

Weighted-average grant date fair value per stock option granted

$

0.23

$

0.28

Risk-free interest rate

0.4%1.4%

1.1% – 3.0%

Expected volatility

43.5%46.4%

32.3% – 37.9%

Dividend yield

0%

0%